Page 15 of 15 · 360 questions tagged semaglutide.
The particulars: SURMOUNT-2 · semaglutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
Numbers first: SUSTAIN-6 · dulaglutide. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence exists…
What I am working with: orforglipron · semaglutide. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
The specifics, since they change the answer: REDEFINE-1 · semaglutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret…
The particulars: REDEFINE-1 · ecnoglutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
The case in front of me: PIONEER-4 · oral semaglutide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me…
What I have: STEP 3 · dulaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Setup, so nobody has to ask: STEP 1 · mazdutide. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Conditions: PIONEER-4 · liraglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
Concretely: SURMOUNT-1 · liraglutide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Can…
What I am working with: SURMOUNT-3 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the…
The case in front of me: STEP 1 · liraglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. This is one of those things that everyone repeats and…
Details up front: STEP 3 · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
I have three data points across nine months, which I hope is enough to see a trend. This is presented as though it settles something, and I am not convinced it does.…
Conditions: REDEFINE-1 · liraglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
Conditions: REDEFINE-1 · oral semaglutide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and…
For reference: SURMOUNT-1 · survodutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
What I am working with: PIONEER-1 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
Concretely: PIONEER-4 · liraglutide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Has…
Concretely: TRIUMPH-1 · oral semaglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
Setup, so nobody has to ask: SUSTAIN-6 · a GLP-1 receptor agonist. I have read the primary source rather than the summary, which has left me with more questions. I…
What I am working with: SURPASS-2 · mazdutide. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
Setup, so nobody has to ask: retatrutide · mazdutide. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…